SS Innovations CEO Outlines Strategy to Expand Affordable Robotic Surgery Globally

SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is charting a path to expand access to robotic surgery by prioritizing affordability, telesurgery, and global regulatory approvals. In a recent interview with Medsider, Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations, outlined the company's strategy to differentiate itself through lower-cost technology and remote surgical capabilities, rather than directly competing with established robotic surgery platforms.

The company's flagship system, the SSi Mantra, was designed to reduce the cost of robotic surgery while supporting multiple specialties, including cardiac surgery. According to Dr. Srivastava, affordability and accessibility remain core priorities as the company expands its surgical robotics platform globally. Artificial intelligence, automation, and new robotic platforms are central to the company's long-term product roadmap.

SS Innovations has installed more than 200 robotic systems and completed more than 11,700 robotic procedures, including over 170 telesurgeries. Telesurgery and teleproctoring are becoming important differentiators, allowing expert surgeons to support complex procedures remotely. The company is pursuing FDA and European regulatory approvals while expanding into additional international markets.

For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. Dr. Srivastava emphasized that SS Innovations' objective is to expand access to hospitals and patients that have historically been unable to adopt robotic surgery because of equipment costs and operating expenses.

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.

MissionIR is a specialized communications platform that assists IR firms with syndicated content to enhance visibility. It is one of 75+ brands within the Dynamic Brand Portfolio @IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and a full array of tailored corporate communications solutions. For more information, visit https://www.MissionIR.com. Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR at https://www.MissionIR.com/Disclaimer.